Identification and Assessment of Necroptosis-Related Genes in Clinical Prognosis and Immune Cells in Diffuse Large B-Cell Lymphoma

Identification and Assessment of Necroptosis-Related Genes in Clinical Prognosis and Immune Cells in Diffuse Large B-Cell Lymphoma

BackgroundWith the unveiling of new mechanisms and the advent of new drugs, the prognosis of diffuse large B-cell lymphoma (DLBCL) becomes promising, but some patients still progress to the relapse or refractory stage. Necroptosis, as a relatively novel programmed cell death, is involved in the deve...

Full description

Bibliographic Details
Main Authors:	Qikai Zhang, Zongsi Zhu, Jiaqiang Guan, Cuiping Zheng
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-06-01
Series:	Frontiers in Oncology
Subjects:	necroptosis diffuse large B-cell lymphoma prognosis tumor microenvironment biomarker
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2022.904614/full

Similar Items

Integrative analysis of a necroptosis-related gene signature of clinical value and heterogeneity in diffuse large B cell lymphoma
by: Yu-Biao Pan, et al.
Published: (2022-08-01)

Retrospective Evaluation of Patients Diagnosed with Diffuse Large B Cell Lymphoma (DLBCL)
by: Atakan TEKİNALP, et al.
Published: (2020-12-01)

The Dark Side of Pyroptosis of Diffuse Large B-Cell Lymphoma in B-Cell Non-Hodgkin Lymphoma: Mediating the Specific Inflammatory Microenvironment
by: Wei Wang, et al.
Published: (2021-11-01)

Influence of Hyperglycemia on the Prognosis of Patients with Diffuse Large B-Cell Lymphoma
by: Zhou W, et al.
Published: (2022-07-01)

A necroptosis-related lncRNA signature was identified to predict the prognosis and immune microenvironment of IDH-wild-type GBM
by: Chong Song, et al.
Published: (2022-12-01)

Identification of molecular subtypes and a novel prognostic model of diffuse large B-cell lymphoma based on a metabolism-associated gene signature
by: Jing He, et al.
Published: (2022-04-01)

High proportion of anergic B cells in the bone marrow defined phenotypically by CD21(−/low)/CD38- expression predicts poor survival in diffuse large B cell lymphoma
by: Sewa Rijal, et al.
Published: (2020-11-01)

Coexpression of CD5 and CD43 predicts worse prognosis in diffuse large B‐cell lymphoma
by: Xiao‐bo Ma, et al.
Published: (2018-09-01)

Prognostic and immunological characterization of diffuse large B-cell lymphoma evaluated by co-stimulatory molecular-related features
by: Lixia Sheng, et al.
Published: (2023-09-01)

Dynamic change of soluble interleukin-2 receptor distinguished molecular heterogeneity and microenvironment alterations in diffuse large B-cell lymphoma
by: Yu-Jia Huo, et al.
Published: (2022-07-01)

Composite lymphoma with coexistence of diffuse large B-cell lymphoma and anaplastic large cell lymphoma: Diagnostic pitfalls
by: Meyyappa Devan Rajagopal, et al.
Published: (2017-01-01)

Immunophenotype classification and therapeutic outcomes of Chinese primary gastrointestinal diffuse large B-cell lymphoma
by: Zhang Zizhen, et al.
Published: (2012-06-01)

Immune infiltration and a necroptosis-related gene signature for predicting the prognosis of patients with cervical cancer
by: Xuewei Xing, et al.
Published: (2023-01-01)

Apoptotic and Non-Apoptotic Modalities of Thymoquinone-Induced Lymphoma Cell Death: Highlight of the Role of Cytosolic Calcium and Necroptosis
by: Mimoune Berehab, et al.
Published: (2021-07-01)

Diffuse Large B-Cell Lymphoma in the HIV Setting
by: Maria Huguet, et al.
Published: (2023-06-01)

Identification of lactate regulation pattern on tumor immune infiltration, therapy response, and DNA methylation in diffuse large B-cell lymphoma
by: Jinghua Wang, et al.
Published: (2023-09-01)

PD‐1 expression on the surface of peripheral blood CD4+ T cell and its association with the prognosis of patients with diffuse large B‐cell lymphoma
by: Wei Zhang, et al.
Published: (2016-11-01)

Primary Diffuse Large B-Cell Lymphoma of the Urinary Tract: A Population-Based Analysis
by: Zheng-Huan Liu, et al.
Published: (2021-07-01)

A novel prognostic model based on four circulating miRNA in diffuse large B‐cell lymphoma: implications for the roles of MDSC and Th17 cells in lymphoma progression
by: Rui Sun, et al.
Published: (2021-01-01)

Prognostic nutritional index and the prognosis of diffuse large b-cell lymphoma: a meta-analysis
by: Chunyan Luan, et al.
Published: (2020-09-01)

The Influence of Serum Leptin Level and Body Mass Index on the Prognosis of Patients with Diffuse Large B Cell Lymphoma
by: Asmaa Mahmoud, et al.
Published: (2023-06-01)

A 9-LncRNA Signature for Predicting Prognosis and Immune Response in Diffuse Large B-Cell Lymphoma
by: Xiaoxuan Wang, et al.
Published: (2022-07-01)

Multiple primary malignancies in 788 Chinese patients with diffuse large B‐cell lymphoma
by: Xuchang Zhang, et al.
Published: (2023-07-01)

A glycolysis-related gene signatures in diffuse large B-Cell lymphoma predicts prognosis and tumor immune microenvironment
by: Yingying Cui, et al.
Published: (2023-01-01)

Survival in patients with oral and maxillofacial diffuse large B-cell lymphoma
by: Janet Ofelia Guevara-Canales, et al.
Published: (2013-11-01)

Prognostic significance of serum aspartic transaminase in diffuse large B-cell lymphoma
by: Ting-Xun Lu, et al.
Published: (2019-06-01)

Crosstalk of necroptosis and pyroptosis defines tumor microenvironment characterization and predicts prognosis in clear cell renal carcinoma
by: Liangmin Fu, et al.
Published: (2022-09-01)

Clinicopathologic implication of PD-L1 and phosphorylated STAT3 expression in diffuse large B cell lymphoma
by: Hyun Jung Kwon, et al.
Published: (2018-11-01)

Primary diffuse large B-cell lymphoma of orbit: A population-based analysis
by: Yu-Qing Chen, et al.
Published: (2022-09-01)

Inflammation marker ESR is effective in predicting outcome of diffuse large B-cell lymphoma
by: Shuang Wu, et al.
Published: (2018-10-01)

CDC6, a key replication licensing factor, is overexpressed and confers poor prognosis in diffuse large B-cell lymphoma
by: Mingfang Shen, et al.
Published: (2023-10-01)

Single-Cell RNA-Seq and Bulk RNA-Seq Reveal Intratumoral Heterogeneity and Tumor Microenvironment Characteristics in Diffuse Large B-Cell Lymphoma
by: Yang Zhao, et al.
Published: (2022-05-01)

Vagal Nerve Activity Predicts Prognosis in Diffused Large B-Cell Lymphoma and Multiple Myeloma
by: Or Atar, et al.
Published: (2023-01-01)

Composite lymphoma associating diffuse large B‐cell lymphoma with classical Hodgkin lymphoma
by: Maïlis Lauwers, et al.
Published: (2022-11-01)

Identification and validation of 5-methylcytosine-associated genes in diffuse large B-cell lymphoma
by: Cheng Xing, et al.
Published: (2023-11-01)

Advances in the Pathogenesis of EBV-Associated Diffuse Large B Cell Lymphoma
by: Paola Chabay
Published: (2021-05-01)

Primary gastrointestinal diffuse large B-cell lymphoma: A prospective study from South India
by: Babu Suresh, et al.
Published: (2019-01-01)

Diffuse Large B Cell Lymphoma of the Breast
by: Feryal Karaca, et al.
Published: (2015-03-01)

Clinical significance of PCDH10 promoter methylation in diffuse large B-cell lymphoma
by: Wenting Huang, et al.
Published: (2017-12-01)

Development and validation of a necroptosis-related gene prognostic score to predict prognosis and efficiency of immunotherapy in gastric cancer
by: Yan Xia, et al.
Published: (2022-08-01)